FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pierre Casellas

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Molecular Sequence Data

Anatomy

Co-author Network

Publications

TOP 3
Carole Voland; Annie Bord; Annick Péleraux; Géraldine Pénarier; Dominique Carrière; Sylvaine Galiègue; Esteban Cvitkovic; Omar Jbilo; Pierre Casellas
Repression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cells.
Omar Jbilo; Christine Ravinet Trillou; Michèle Arnone; Isabelle Buisson; Estelle Bribes; Annick Péleraux; Géraldine Pénarier; Philippe Soubrié; Gérard Le-Fur; Sylvaine Galiègue; Pierre Casellas
The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
Monsif Bouaboula; Sandrine Hilairet; Jean Marchand; Lluis Fajas; Gérard Le-Fur; Pierre Casellas
Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pierre Casellas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Carole Voland; Annie Bord; Annick Péleraux; Géraldine Pénarier; Dominique Carrière; Sylvaine Galiègue; Esteban Cvitkovic; Omar Jbilo; Pierre Casellas
Repression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cells.
Molecular cancer therapeutics 2006;5(9):2149-57.
2005: Omar Jbilo; Christine Ravinet Trillou; Michèle Arnone; Isabelle Buisson; Estelle Bribes; Annick Péleraux; Géraldine Pénarier; Philippe Soubrié; Gérard Le-Fur; Sylvaine Galiègue; Pierre Casellas
The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(11):1567-9.
2005: Monsif Bouaboula; Sandrine Hilairet; Jean Marchand; Lluis Fajas; Gérard Le-Fur; Pierre Casellas
Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.
European journal of pharmacology 2005;517(3):174-81.
2004: Bernard Bourrie; Estelle Bribes; Jean-Marie Derocq; Hubert Vidal; Pierre Casellas
Sigma receptor ligands: applications in inflammation and oncology.
Current opinion in investigational drugs (London, England : 2000) 2004;5(11):1158-63.
2004: Sylvaine Galiègue; Pierre Casellas; Andrew Kramar; Norbert Tinel; Joelle Simony-Lafontaine
Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):2058-64.
2004: Pierre Casellas; Sylvaine Galiegue; Bernard Bourrie; Jean-Bernard Ferrini; Omar Jbilo; Hubert Vidal
SR31747A: a peripheral sigma ligand with potent antitumor activities.
Anti-cancer drugs 2004;15(2):113-8.
2004: Pierrick Rochard; Sylvaine Galiegue; Norbert Tinel; Annick Peleraux; Annie Bord; Omar Jbilo; Pierre Casellas
Expression of the peripheral benzodiazepine receptor triggers thymocyte differentiation.
Gene expression 2004;12(1):13-27.
2004: Estelle Bribes; Dominique Carrière; Catherine Goubet; Sylvaine Galiègue; Pierre Casellas; Joelle Simony-Lafontaine
Immunohistochemical assessment of the peripheral benzodiazepine receptor in human tissues.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2004;52(1):19-28.
2003: Estelle Bribes; Bernard Bourrie; Pierre Casellas
Ligands of the peripheral benzodiazepine receptor have therapeutic effects in pneumopathies in vivo.
Immunology letters 2003;88(3):241-7.
2003: Hubert Vidal; Guillaume Mondesert; Sylvaine Galiègue; Dominique Carrière; Pascal-Henri Dupuy; Pierre Carayon; Thérèse Combes; Estelle Bribes; Joelle Simony-Lafontaine; Andrew Kramar; Gérard Loison; Pierre Casellas
Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding protein.
Cancer research 2003;63(16):4809-18.
2003: Sylvaine Galiegue; Norbert Tinel; Pierre Casellas
The peripheral benzodiazepine receptor: a promising therapeutic drug target.
Current medicinal chemistry 2003;10(16):1563-72.
2003: Sandrine Hilairet; Monsif Bouaboula; Dominique Carrière; Gérard Le-Fur; Pierre Casellas
Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716.
The Journal of biological chemistry 2003;278(26):23731-7.
2003: Antoine Gross; Monsif Bouaboula; Pierre Casellas; Jean-Pierre Liautard; Jacques Dornand
Subversion and utilization of the host cell cyclic adenosine 5'-monophosphate/protein kinase A pathway by Brucella during macrophage infection.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(11):5607-14.
2003: Y Berthois; Bernard Bourrié; Sylvaine Galiègue; Hubert Vidal; Pierre Carayon; Pierre-Marie Martin; Pierre Casellas
SR31747A is a sigma receptor ligand exhibiting antitumoural activity both in vitro and in vivo.
British journal of cancer 2003;88(3):438-46.
2003: Estelle Bribes; Sylvaine Galiegue; Bernard Bourrie; Pierre Casellas
Involvement of the peripheral benzodiazepine receptor in the development of cutaneous pathology in Mrl/Lpr mice.
Immunology letters 2003;85(1):13-8.
2003: Jean-Bernard Ferrini; Omar Jbilo; Annick Peleraux; Thérèse Combes; Hubert Vidal; Sylvaine Galiegue; Pierre Casellas
Transcriptomic classification of antitumor agents: application to the analysis of the antitumoral effect of SR31747A.
Gene expression 2003;11(3-4):125-39.
2003: S I Gilles; Sylvie Romain; Pierre Casellas; L'Houcine Ouafik; Frederic Fina; Thérèse Combes; V Vuaroquaux; J F Seitz; Pascal Bonnier; Sylvaine Galiègue; Pierre Carayon; Pierre-Marie Martin
Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer.
The International journal of biological markers 2003;18(1):1-6.
2002: Bernard Bourrié; Estelle Bribes; Nathalie De Nys; Martine Esclangon; Laurent Garcia; Sylvaine Galiègue; Pierre Lair; Raymond Paul; Corinne Thomas; Jean-Claude Vernières; Pierre Casellas
SSR125329A, a high affinity sigma receptor ligand with potent anti-inflammatory properties.
European journal of pharmacology 2002;456(1-3):123-31.
2002: Pascale Chardenot; Christine Roubert; Sylvaine Galiègue; Pierre Casellas; Gérard Le-Fur; Philippe Soubrié; Florence Oury-Donat
Expression profile and up-regulation of PRAX-1 mRNA by antidepressant treatment in the rat brain.
Molecular pharmacology 2002;62(6):1314-20.
2002: Estelle Bribes; Bernard Bourrie; Martine Esclangon; Sylvaine Galiegue; Hubert Vidal; Pierre Casellas
Involvement of the peripheral benzodiazepine receptor in the development of rheumatoid arthritis in Mrl/lpr mice.
European journal of pharmacology 2002;452(1):111-22.
2002: Allyn C Howlett; Francis Barth; Tom Bonner; G Cabral; Pierre Casellas; W A Devane; Christian Felder; Miles Herkenham; Ken Mackie; Billy R Martin; Urij Rampampam; R G Pertwee
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
Pharmacological reviews 2002;54(2):161-202.
2002: Pierre Casellas; Sylvaine Galiegue; Anthony Basile
Peripheral benzodiazepine receptors and mitochondrial function.
Neurochemistry international 2002;40(6):475-86.
2002: L'Houcine Ouafik; Samantha Sauze; Françoise Boudouresque; Olivier Chinot; Christine Delfino; Frederic Fina; Vincent Vuaroqueaux; Christophe Dussert; Jacqueline Palmari; Henry Dufour; François Grisoli; Pierre Casellas; Nils Brünner; Pierre-Marie Martin
Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.
The American journal of pathology 2002;160(4):1279-92.
2002: Sylvaine Galiègue; Pierre Casellas
[Exploitation of expression profiles: examples in oncology].
Journal de la Société de biologie 2002;196(4):313-5.
2002: Elisa Cinato; Annick Péléraux; Sandra Silve; Sylvaine Galiègue; Christiane Dhers; Claudine Picard; Omar Jbilo; Gérard Loison; Pierre Casellas
A DNA microarray-based approach to elucidate the effects of the immunosuppressant SR31747A on gene expression in Saccharomyces cerevisiae.
Gene expression 2002;10(5-6):213-30.
2002: Estelle Bribes; Pierre Casellas; Hubert Vidal; Danielle Dussossoy; Daniel Casellas
Peripheral benzodiazepine receptor mapping in rat kidney. Effects of angiotensin II-induced hypertension.
Journal of the American Society of Nephrology : JASN 2002;13(1):1-9.
2001: Pierre-Emmanuel Stoebner; P Carayon; Pierre Casellas; M Portier; Thierry Lavabre-Bertrand; Pierre Cuq; Jean-Paul Cano; Jean Meynadier; Laurent Meunier
Transient protection by peripheral benzodiazepine receptors during the early events of ultraviolet light-induced apoptosis.
Cell death and differentiation 2001;8(7):747-53.
2000: Claudine Serradeil-Le Gal; Max LAFONTAN; Danielle Raufaste; Jean Marchand; Brigitte Pouzet; Pierre Casellas; Marc Pascal; Jean-Pierre Maffrand; Gérard Le-Fur
Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes.
FEBS letters 2000;475(2):150-6.
2000: Joelle Simony-Lafontaine; M Esslimani; Estelle Bribes; Sophie Gourgou; N Lequeux; R Lavail; Jean Grenier; Andrew Kramar; Pierre Casellas
Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors.
British journal of cancer 2000;82(12):1958-66.
2000: Jean-Marie Derocq; Omar Jbilo; Monsif Bouaboula; M Ségui; C Clère; Pierre Casellas
Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation.
The Journal of biological chemistry 2000;275(21):15621-8.
2000: P Cohen; Monsif Bouaboula; M Bellis; V Baron; Omar Jbilo; C Poinot-Chazel; Sylvaine Galiègue; E H Hadibi; Pierre Casellas
Monitoring cellular responses to Listeria monocytogenes with oligonucleotide arrays.
The Journal of biological chemistry 2000;275(15):11181-90.
2000: Antoine Gross; Annie Terraza; J Marchant; Monsif Bouaboula; Safia Ouahrani-Bettache; Jean-Pierre Liautard; Pierre Casellas; Jacques Dornand
A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis.
Journal of leukocyte biology 2000;67(3):335-44.
1999: Bernard Bourrié; Estelle Bribes; Martine Esclangon; L Garcia; Jean Marchand; C Thomas; Jean-Pierre Maffrand; Pierre Casellas
The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(22):12855-9.
1999: Monsif Bouaboula; Danielle Dussossoy; Pierre Casellas
Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses.
The Journal of biological chemistry 1999;274(29):20397-405.
1999: Danielle Dussossoy; Pierre Carayon; S Belugou; D Feraut; Annie Bord; C Goubet; C Roque; Hubert Vidal; Thérèse Combes; Gérard Loison; Pierre Casellas
Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level.
European journal of biochemistry / FEBS 1999;263(2):377-86.
1999: Pierre-Emmanuel Stoebner; P Carayon; G Penarier; N Fréchin; G Barnéon; Pierre Casellas; Jean-Paul Cano; Jean Meynadier; Laurent Meunier
The expression of peripheral benzodiazepine receptors in human skin: the relationship with epidermal cell differentiation.
The British journal of dermatology 1999;140(6):1010-6.
1999: Monsif Bouaboula; L Bianchini; F R McKenzie; J Pouyssegur; Pierre Casellas
Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways.
FEBS letters 1999;449(1):61-5.
1999: Omar Jbilo; Jean-Marie Derocq; M Segui; Gérard Le-Fur; Pierre Casellas
Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60.
FEBS letters 1999;448(2-3):273-7.
1999: Jean Marchand; Annie Bord; Géraldine Pénarier; F Lauré; Pierre Carayon; Pierre Casellas
Quantitative method to determine mRNA levels by reverse transcriptase-polymerase chain reaction from leukocyte subsets purified by fluorescence-activated cell sorting: application to peripheral cannabinoid receptors.
Cytometry 1999;35(3):227-34.
1999: Monsif Bouaboula; Nathalie Desnoyer; Pierre Carayon; Thérèse Combes; Pierre Casellas
Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation.
Molecular pharmacology 1999;55(3):473-80.
1999: M Portier; Murielle Rinaldi-Carmona; F Pecceu; Thérèse Combes; C Poinot-Chazel; B Calandra; Francis Barth; Gérard Le-Fur; Pierre Casellas
SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.
The Journal of pharmacology and experimental therapeutics 1999;288(2):582-9.
1999: Sylvaine Galiègue; Omar Jbilo; Thérèse Combes; Estelle Bribes; Pierre Carayon; Gérard Le-Fur; Pierre Casellas
Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor.
The Journal of biological chemistry 1999;274(5):2938-52.
1999: David Shire; B Calandra; Monsif Bouaboula; Francis Barth; Murielle Rinaldi-Carmona; Pierre Casellas; Pascual Ferrara
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.
Life sciences 1999;65(6-7):627-35.
1998: Murielle Rinaldi-Carmona; A Le Duigou; Didier Oustric; Francis Barth; Monsif Bouaboula; Pierre Carayon; Pierre Casellas; Gérard Le-Fur
Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system.
The Journal of pharmacology and experimental therapeutics 1998;287(3):1038-47.
1998: Pierre Carayon; Jean Marchand; Danielle Dussossoy; Jean-Marie Derocq; Omar Jbilo; Annie Bord; Monsif Bouaboula; Sylvaine Galiègue; Paul Mondière; Géraldine Pénarier; G L Fur; Thierry Defrance; Pierre Casellas
Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation.
Blood 1998;92(10):3605-15.
1998: Natalio VITA; Florence Oury-Donat; Pascale Chalon; M Guillemot; Mourad Kaghad; A Bachy; O Thurneyssen; S Garcia; C Poinot-Chazel; Pierre Casellas; Peter Keane; Gérard Le-Fur; Jean-Pierre Maffrand; Philippe Soubrie; Daniel Caput; Pascual Ferrara
Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells.
European journal of pharmacology 1998;360(2-3):265-72.
1998: M Portier; Thérèse Combes; Danielle Gully; Jean-Pierre Maffrand; Pierre Casellas
Neurotensin type 1 receptor-mediated activation of krox24, c-fos and Elk-1: preventing effect of the neurotensin antagonists SR 48692 and SR 142948.
FEBS letters 1998;432(1-2):88-93.
1998: Raymond Paul; Sandra Silve; Nathalie De Nys; Pascal-Henri Dupuy; C L Bouteiller; J Rosenfeld; Pascual Ferrara; Gérard Le-Fur; Pierre Casellas; Gérard Loison
Both the immunosuppressant SR31747 and the antiestrogen tamoxifen bind to an emopamil-insensitive site of mammalian Delta8-Delta7 sterol isomerase.
The Journal of pharmacology and experimental therapeutics 1998;285(3):1296-302.
1998: Jean-Marie Derocq; Monsif Bouaboula; Jean Marchand; Murielle Rinaldi-Carmona; M Ségui; Pierre Casellas
The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
FEBS letters 1998;425(3):419-25.
1998: Murielle Rinaldi-Carmona; Francis Barth; J Millan; Jean-Marie Derocq; Pierre Casellas; C Congy; Didier Oustric; M Sarran; Monsif Bouaboula; B Calandra; M Portier; David Shire; J C Brelière; Gérard Le-Fur
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
The Journal of pharmacology and experimental therapeutics 1998;284(2):644-50.
1997: Omar Jbilo; Hubert Vidal; Raymond Paul; Nathalie De Nys; Mohammed Bensaid; Sandra Silve; Pierre Carayon; D Davi; Sylvaine Galiègue; Bernard Bourrié; J C Guillemot; Pascual Ferrara; Gérard Loison; Jean-Pierre Maffrand; Gérard Le-Fur; Pierre Casellas
Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomerase.
The Journal of biological chemistry 1997;272(43):27107-15.
1997: Monsif Bouaboula; S Perrachon; L Milligan; X Canat; Murielle Rinaldi-Carmona; M Portier; Francis Barth; B Calandra; F Pecceu; J Lupker; Jean-Pierre Maffrand; Gérard Le-Fur; Pierre Casellas
A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.
The Journal of biological chemistry 1997;272(35):22330-9.
1996: Jean-Marie Derocq; M Ségui; C Blazy; Xavier Emonds-Alt; Gérard Le-Fur; J C Brelire; Pierre Casellas
Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists.
FEBS letters 1996;399(3):321-5.
1996: C Poinot-Chazel; M Portier; Monsif Bouaboula; Natalio VITA; F Pecceu; D Gully; J G Monroe; Jean-Pierre Maffrand; Gérard Le-Fur; Pierre Casellas
Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24.
The Biochemical journal 1996;320 ( Pt 1)():145-51.
1996: Murielle Rinaldi-Carmona; B Calandra; David Shire; Monsif Bouaboula; D Oustric; Francis Barth; Pierre Casellas; Pascual Ferrara; Gérard Le-Fur
Characterization of two cloned human CB1 cannabinoid receptor isoforms.
The Journal of pharmacology and experimental therapeutics 1996;278(2):871-8.
1996: Bernard Bourrié; J M Benoît; Jean-Marie Derocq; M Esclangon; C Thomas; Gérard Le-Fur; Pierre Casellas
A sigma ligand, SR 31747A, potently modulates Staphylococcal enterotoxin B-induced cytokine production in mice.
Immunology 1996;88(3):389-93.
1996: Danielle Dussossoy; S Belugou; G Pastor; J Combalbert; Pierre Casellas
Development of a radioimmunoassay for SR 31747A, a new sigma ligand, in human plasma.
Journal of pharmaceutical and biomedical analysis 1996;14(7):783-91.
1996: Pierre Carayon; G Petitpretre; B Bourrie; Gérard Le-Fur; Pierre Casellas
In vivo effects of a new immunosuppressive sigma ligand, SR 31747, on mouse thymus.
Immunopharmacology and immunotoxicology 1996;18(2):179-91.
1996: Danielle Dussossoy; Pierre Carayon; D Feraut; S Belugou; Thérèse Combes; X Canat; Hubert Vidal; Pierre Casellas
Development of a monoclonal antibody to immuno-cytochemical analysis of the cellular localization of the peripheral benzodiazepine receptor.
Cytometry 1996;24(1):39-48.
1996: Monsif Bouaboula; C Poinot-Chazel; Jean Marchand; X Canat; Bernard Bourrié; Murielle Rinaldi-Carmona; B Calandra; Gérard Le-Fur; Pierre Casellas
Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.
European journal of biochemistry / FEBS 1996;237(3):704-11.
1996: Pierre Carayon; M Portier; Danielle Dussossoy; Annie Bord; G Petitprêtre; X Canat; Gérard Le-Fur; Pierre Casellas
Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage.
Blood 1996;87(8):3170-8.
1996: Jean-Marc Herbert; Alain Lalé; J M Pereillo; Jean-Marie Derocq; Pierre Casellas
Echinomycin suppresses the pyrogenic effects of endotoxin and interleukin-1 beta in human endothelial cells and peripheral blood mononuclear cells.
Thrombosis and haemostasis 1996;75(2):359-62.
1995: Monsif Bouaboula; C Poinot-Chazel; Bernard Bourrié; X Canat; B Calandra; Murielle Rinaldi-Carmona; Gérard Le-Fur; Pierre Casellas
Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
The Biochemical journal 1995;312 ( Pt 2)():637-41.
1995: T Fischer; Robert Zumbihl; J Armand; Pierre Casellas; Bruno Rouot
Prolonged elevation of intracellular cyclic AMP levels in U937 cells increases the number of receptors for and the responses to formylmethionyl-leucylphenylalanine, independently of the differentiation process.
The Biochemical journal 1995;311 ( Pt 3)():995-1000.
1995: B Bourrie; Monsif Bouaboula; J M Benoit; Jean-Marie Derocq; M Esclangon; Gérard Le-Fur; Pierre Casellas
Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a sigma ligand.
European journal of immunology 1995;25(10):2882-7.
1995: Pierre Carayon; Monsif Bouaboula; J F Loubet; B Bourrie; G Petitpretre; Gérard Le-Fur; Pierre Casellas
The sigma ligand SR 31747 prevents the development of acute graft-versus-host disease in mice by blocking IFN-gamma and GM-CSF mRNA expression.
International journal of immunopharmacology 1995;17(9):753-61.
1995: Sylvaine Galiègue; S Mary; Jean Marchand; Danielle Dussossoy; D Carrière; Pierre Carayon; Monsif Bouaboula; David Shire; Gérard Le-Fur; Pierre Casellas
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
European journal of biochemistry / FEBS 1995;232(1):54-61.
1995: Jean-Marie Derocq; M Ségui; Jean Marchand; Gérard Le-Fur; Pierre Casellas
Cannabinoids enhance human B-cell growth at low nanomolar concentrations.
FEBS letters 1995;369(2-3):177-82.
1995: Robert Zumbihl; Jacques Dornand; T Fischer; S Cabane; R Rappuoli; Monsif Bouaboula; Pierre Casellas; Bruno Rouot
IL-1 stimulates a diverging signaling pathway in EL4 6.1 thymoma cells. IL-2 release, but not IL-2 receptor expression, is sensitive to pertussis toxin.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(1):181-9.
1995: Monsif Bouaboula; Bernard Bourrié; Murielle Rinaldi-Carmona; David Shire; Gérard Le-Fur; Pierre Casellas
Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells.
The Journal of biological chemistry 1995;270(23):13973-80.
1995: Jean-Marie Derocq; Bernard Bourrié; M Ségui; Gérard Le-Fur; Pierre Casellas
In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.
The Journal of pharmacology and experimental therapeutics 1995;272(1):224-30.
1994: Pierre Casellas; Bernard Bourrié; X Canat; Pierre Carayon; I Buisson; R Paul; JC Brelière; Gérard Le-Fur
Immunopharmacological profile of SR 31747: in vitro and in vivo studies on humoral and cellular responses.
Journal of neuroimmunology 1994;52(2):193-203.
1994: R Paul; S Lavastre; D Floutard; R Floutard; X Canat; Pierre Casellas; Gérard Le-Fur; JC Brelière
Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747.
Journal of neuroimmunology 1994;52(2):183-92.
1994: Jean-Marie Derocq; M Segui; C Poinot-Chazel; A Minty; Daniel Caput; Pascual Ferrara; Pierre Casellas
Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4.
FEBS letters 1994;343(1):32-6.
1994: Claudine Serradeil-Le Gal; Bernard Bourrié; Danielle Raufaste; Pierre Carayon; C Garcia; Jean-Pierre Maffrand; Gérard Le-Fur; Pierre Casellas
Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells.
Biochemical pharmacology 1994;47(4):633-41.
1994: Murielle Rinaldi-Carmona; V Prabonnaud; Monsif Bouaboula; C Poinot-Chazel; Pierre Casellas; Gérard Le-Fur; J M Herbert
Regulation of 5-hydroxytryptamine2 (5-HT2) receptor expression in cultured rat aortic smooth muscle cells by SR 46349B, a selective 5-HT2 receptor antagonist.
The Journal of biological chemistry 1994;269(1):396-401.
1994: D Cahard; X Canat; Pierre Carayon; C Roque; Pierre Casellas; Gérard Le-Fur
Subcellular localization of peripheral benzodiazepine receptors on human leukocytes.
Laboratory investigation; a journal of technical methods and pathology 1994;70(1):23-8.
1993: X Canat; A Guillaumont; Monsif Bouaboula; C Poinot-Chazel; Jean-Marie Derocq; Pierre Carayon; G LeFur; Pierre Casellas
Peripheral benzodiazepine receptor modulation with phagocyte differentiation.
Biochemical pharmacology 1993;46(3):551-4.
1993: Murielle Rinaldi-Carmona; Monsif Bouaboula; C Congy; Florence Oury-Donat; Jacques Simiand; David Shire; Pierre Casellas; Philippe Soubrié; JC Brelière; Gérard Le-Fur
Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.
European journal of pharmacology 1993;246(1):73-80.
1993: Monsif Bouaboula; M Rinaldi; P Carayon; C Carillon; B Delpech; David Shire; Gérard Le-Fur; Pierre Casellas
Cannabinoid-receptor expression in human leukocytes.
European journal of biochemistry / FEBS 1993;214(1):173-80.
1993: X Canat; Pierre Carayon; Monsif Bouaboula; D Cahard; David Shire; C Roque; Gérard Le-Fur; Pierre Casellas
Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells.
Life sciences 1993;52(1):107-18.
1992: Monsif Bouaboula; P Legoux; B Pességué; B Delpech; X Dumont; Marc Piechaczyk; Pierre Casellas; David Shire
Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control.
The Journal of biological chemistry 1992;267(30):21830-8.
1992: Jacques Dornand; Monsif Bouaboula; A D d'Angeac; Jean Favero; David Shire; Pierre Casellas
Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin-1 and phorbol ester activation pathways in the EL4-6.1 thymoma cell line.
Journal of cellular physiology 1992;151(1):71-80.
1992: S Ravel; M Colombatti; Pierre Casellas
Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells.
Blood 1992;79(6):1511-7.
1991: O Rostaing-Capaillon; Pierre Casellas
In vivo cytotoxic efficacy of immunotoxins prepared from anti-CD5 antibody linked to ricin A-chain.
Cancer immunology, immunotherapy : CII 1991;34(1):24-30.
1990: S Ravel; Pierre Casellas
Internalization of the cytotoxic molecules of T101 F(ab')2-(ricin-A-chain) immunotoxin into human T-leukemic cells.
European journal of biochemistry / FEBS 1990;192(2):469-73.
1990: O Rostaing-Capaillon; Pierre Casellas
Parameters affecting tumor-specific delivery of anti-CD5 antibody-ricin A chain immunotoxins in vivo.
Cancer research 1990;50(10):2909-16.
1989: A A Hertler; D M Schlossman; Michael J Borowitz; H E Blythman; Pierre Casellas; A E Frankel
An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensin.
International journal of cancer. Journal international du cancer 1989;43(2):215-9.
1989: P Carayon; Pierre Casellas; F K Jansen
Biochemical engineering of immunotoxins for ex vivo bone marrow transplantation and in vivo leukemia treatment.
Targeted diagnosis and therapy 1989;2():41-52.
1988: Jean-Marie Derocq; Pierre Casellas; G Laurent; S Ravel; Hubert Vidal; F Jansen
Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(8):2837-43.
1988: Pierre Casellas; Danielle Dussossoy; A I Falasca; Luigi Barbieri; J C Guillemot; Pascual Ferrara; Andrea Bolognesi; P Cenini; Fiorenzo Stirpe
Trichokirin, a ribosome-inactivating protein from the seeds of Trichosanthes kirilowii Maximowicz. Purification, partial characterization and use for preparation of immunotoxins.
European journal of biochemistry / FEBS 1988;176(3):581-8.
1988: Pierre Casellas; S Ravel; Bernard Bourrié; Jean-Marie Derocq; F K Jansen; G Laurent; P Gros
T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic amines.
Blood 1988;72(4):1197-202.
1988: F K Jansen; B Bourrie; Pierre Casellas; Danielle Dussossoy; O Gros; P Vic; Hubert Vidal; P Gros
Toxin selection and modification: utilization of the A chain of ricin.
Cancer treatment and research 1988;37():97-111.
1988: Pierre Casellas; F K Jansen
Immunotoxin enhancers.
Cancer treatment and research 1988;37():351-69.
1988: G Laurent; A E Frankel; A A Hertler; D M Schlossman; Pierre Casellas; F K Jansen
Treatment of leukemia patients with T101 ricin A chain immunotoxins.
Cancer treatment and research 1988;37():483-91.
1987: Jean-Marie Derocq; G Laurent; Pierre Casellas; Hubert Vidal; P Poncelet; A Fauser; Cécile Demur; F Jansen
Rationale for the selection of ricin A-chain anti-T immunotoxins for mature T cell depletion.
Transplantation 1987;44(6):763-9.
1986: Guy Laurent; J Pris; J P Farcet; Pierre Carayon; H Blythman; Pierre Casellas; P Poncelet; F K Jansen
Effects of therapy with T101 ricin A-chain immunotoxin in two leukemia patients.
Blood 1986;67(6):1680-7.
1986: Guy Laurent; Emilienne Kuhlein; Pierre Casellas; X Canat; Pierre Carayon; P Poncelet; S Correll; F Rigal; F K Jansen
Determination of sensitivity of fresh leukemia cells to immunotoxins.
Cancer research 1986;46(5):2289-94.
1986: B J Bourrie; Pierre Casellas; H E Blythman; F K Jansen
Study of the plasma clearance of antibody--ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A chain that mediate rapid clearance of the immunotoxin.
European journal of biochemistry / FEBS 1986;155(1):1-10.
1985: Hubert Vidal; Pierre Casellas; P Gros; F K Jansen
Studies on components of immunotoxins: purification of ricin and its subunits and influence of unreacted antibodies.
International journal of cancer. Journal international du cancer 1985;36(6):705-11.
1985: Pierre Casellas; X Canat; A A Fauser; O Gros; Guy Laurent; P Poncelet; F K Jansen
Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin.
Blood 1985;65(2):289-97.
1985: D Carrière; Pierre Casellas; G Richer; P Gros; F K Jansen
Endocytosis of an antibody ricin A-chain conjugate (immuno-A-toxin) adsorbed on colloidal gold. Effects of ammonium chloride and monensin.
Experimental cell research 1985;156(2):327-40.
1985: L Douay; N C Gorin; M Lopez; Pierre Casellas; M C Liance; F K Jansen; G A Voisin; C Baillou; J P Laporte; A Najman
Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantation.
Cancer research 1985;45(1):438-41.
1984: Pierre Casellas; B J Bourrie; P Gros; F K Jansen
Kinetics of cytotoxicity induced by immunotoxins. Enhancement by lysosomotropic amines and carboxylic ionophores.
The Journal of biological chemistry 1984;259(15):9359-64.
1984: P Poncelet; H E Blythman; D Carriere; Pierre Casellas; Danielle Dussossoy; O Gros; P Gros; F K Jansen; J C Laurent; M C Liance
Present potential of immunotoxins.
Behring Institute Mitteilungen 1984;(74):94-100.
1983: F K Jansen; H E Blythman; D Carrière; Pierre Casellas; Danielle Dussossoy; O Gros; P Gros; J C Laurent; F Paolucci; B Pau; P Poncelet; G Richer; Hubert Vidal; G A Voisin
[Immunotoxins].
Bulletin du cancer 1983;70(3):165-8.
1982: Pierre Casellas; J P Brown; O Gros; P Gros; I Hellström; F K Jansen; P Poncelet; R Roncucci; Hubert Vidal; K E Hellström
Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97.
International journal of cancer. Journal international du cancer 1982;30(4):437-43.
1982: F K Jansen; H E Blythman; D Carrière; Pierre Casellas; O Gros; P Gros; J C Laurent; F Paolucci; B Pau; P Poncelet; G Richer; Hubert Vidal; G A Voisin
Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity.
Immunological reviews 1982;62():185-216.
1981: H E Blythman; Pierre Casellas; O Gros; P Gros; F K Jansen; F Paolucci; B Pau; Hubert Vidal
Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells.
Nature 1981;290(5802):145-6.